(NOW) Stock Price prediction Medite Cancer Diagnostics Inc in 2030

Updated: 2023-10-16

Updated Stock Price Medite Cancer Diagnostics Inc plc (Medite Cancer Diagnostics Inc)

MDIT-USD Medite Cancer Diagnostics Inc - USD Dollar
0.0001000000 0% (0)

You are interested in stocks Medite Cancer Diagnostics Inc plc and you would like to buy it, and maybe you already have it in your portfolio? If so, on this page you will find helpful information about the dynamics of the share price Medite Cancer Diagnostics Inc in 2030 How much will the share be worth Medite Cancer Diagnostics Inc in 2030?

Stock historical and prediction chart Medite Cancer Diagnostics Inc

The chart below shows the historical price fluctuation of the stock Medite Cancer Diagnostics Inc and a prediction chart for the next month. For simplicity, costs are divided into colors. Prediction prices include an optimistic prediction, a pessimistic prediction and a weighted average of the best prediction. Detailed share price values Medite Cancer Diagnostics Inc can be found in the table below.

Long-term predictions by year.

Medite Cancer Diagnostics Inc monthly stock prediction for 2030

Data Target Opt. Pes. Vol. %
Jan 0.11818 0.12563 0.11052 13.67%
Feb 0.10669 0.11376 0.09989 13.89%
Mar 0.11028 0.11548 0.10304 12.07%
Apr 0.11288 0.1211 0.1055 14.79%
May 0.11309 0.12089 0.10515 14.97%
Jun 0.1001 0.1067 0.09473 12.64%
Jul 0.09323 0.10058 0.08616 16.74%
Aug 0.10145 0.10827 0.09393 15.27%
Sep 0.10813 0.11565 0.10124 14.23%
Oct 0.11481 0.12289 0.10947 12.26%
Fox 0.12831 0.13548 0.12297 10.17%
Dec 0.13344 0.13871 0.12634 9.79%

Prediction Medite Cancer Diagnostics Inc for this year

Stock predict Medite Cancer Diagnostics Inc for 01-2030.

Uptrend prediction for this month with optimal price target at $0.11818.

Pessimistic: $0.11052.

Optimistic: $0.12563.

Stock predict Medite Cancer Diagnostics Inc for 02-2030.

Uptrend prediction for this month with optimal price target at $0.10669.

Pessimistic: $0.09989.

Optimistic: $0.11376.

Stock predict Medite Cancer Diagnostics Inc for 03-2030.

Uptrend prediction for this month with optimal price target at $0.11028.

Pessimistic: $0.10304.

Optimistic: $0.11548.

Stock predict Medite Cancer Diagnostics Inc for 04-2030.

Uptrend prediction for this month with optimal price target at $0.11288.

Pessimistic: $0.1055.

Optimistic: $0.1211.

Stock predict Medite Cancer Diagnostics Inc for 05-2030.

Uptrend prediction for this month with optimal price target at $0.11309.

Pessimistic: $0.10515.

Optimistic: $0.12089.

Info

When to take profits on stocks Medite Cancer Diagnostics Inc? When to take a loss on stocks Medite Cancer Diagnostics Inc? What are analyst prediction for the stock Medite Cancer Diagnostics Inc? What does the future hold for stocks Medite Cancer Diagnostics Inc?

We predict stock results Medite Cancer Diagnostics Inc using neural networks based on historical data about shares Medite Cancer Diagnostics Inc. In addition, the Prediction uses technical analysis tools and takes into account geopolitical factors and news from around the world.

The goal is to find an investment strategy that will provide above-average returns in all market conditions. Our predict MDIT is updated daily to help investors know whether now is a good time to buy or sell stocks MDIT.

Stock prediction results Medite Cancer Diagnostics Inc are presented in the form of charts, tables and text information divided into time intervals.

The final prices of instruments at the close of the previous trading day are a signal to revise the stock prediction Medite Cancer Diagnostics Inc. It happens once a day.

Statement

All prediction data on the website is provided for informational purposes for the use of neural predicting tools in the financial market and does not constitute a solicitation for trading, nor is it a trading signal. By using prediction data, the investor assumes all financial risk. The EURUSD.site website is not responsible for the loss of your money on the stock exchange as a result of using the information contained on the website.